Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes ERAS-0015, a pan-RAS mol...
Leadership
Jonathan E. Lim M.D.Founder
Co-Founder, Chairman & CEO
David M. Chacko M.D.
CFO & Chief Business Officer
Michael D. Varney Ph.D.
Chairman of Research & Development, Scientific Advisory Board Member and Director
